Eagle Pharmaceuticals: 3Q Earnings Snapshot

November 12, 2019

WOODCLIFF LAKE, N.J. (AP) _ Eagle Pharmaceuticals Inc. (EGRX) on Tuesday reported a third-quarter loss of $2.4 million, after reporting a profit in the same period a year earlier.

On a per-share basis, the Woodcliff Lake, New Jersey-based company said it had a loss of 17 cents. Earnings, adjusted for stock option expense and non-recurring costs, came to 26 cents per share.

The specialty pharmaceutical company posted revenue of $41.1 million in the period.

Eagle Pharmaceuticals shares have increased 53% since the beginning of the year. The stock has risen 19% in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on EGRX at https://www.zacks.com/ap/EGRX